Vascular Solutions Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- Wall St futures tick up as investors weigh earnings; PayPal jumps
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices rise 1% as hostilities worsen in the Middle East
- ASML capacity upgrade soothes AI chip bottleneck fears
- Dollar steadies as Middle East escalation counters soft US inflation
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Kosovo bans Serb minister over ethnic cleansing remarks
- Lucid Group shares quickly cut in half on report of potential bankruptcy
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
Needham & Company Reiterates Buy on Vascular Solutions (VASC) Following 3Q Report
October 25, 2016 8:32 AM EDTNeedham & Company reiterated a Buy rating and $58.00 price target on Vascular Solutions (NASDAQ: VASC) following the company's 3Q earnings report. Revenue was reported in-line with consensus at $41.8M. Adjusted EPS was $0.31 vs. consensus of $0.30. The EPS upside was driven by a lower than expected... More
Vascular Solutions (VASC) Tops Q3 EPS by 1c; Issues Solid Outlook
October 24, 2016 4:09 PM EDTVascular Solutions (NASDAQ: VASC) reported Q3 EPS of $0.31, $0.01 better than the analyst estimate of $0.30. Revenue for the quarter came in at $41.8 million versus the consensus estimate of $41.65 million.
GUIDANCE:
Vascular Solutions sees Q4 2016 EPS of $0.34-$0.36, versus the consensus of... More
